 Matthew Frank
Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 26 | 2024 | 228 | 5.640 |
Why?
| | Hippocampus | 30 | 2025 | 802 | 3.420 |
Why?
| | HMGB1 Protein | 8 | 2019 | 48 | 2.580 |
Why?
| | Lipopolysaccharides | 19 | 2024 | 856 | 2.580 |
Why?
| | Glucocorticoids | 14 | 2019 | 575 | 2.530 |
Why?
| | Inflammasomes | 7 | 2023 | 128 | 2.350 |
Why?
| | Stress, Psychological | 14 | 2019 | 1062 | 2.330 |
Why?
| | Inflammation | 24 | 2024 | 2668 | 2.040 |
Why?
| | Inflammation Mediators | 7 | 2018 | 500 | 1.830 |
Why?
| | Rats, Sprague-Dawley | 35 | 2025 | 2245 | 1.770 |
Why?
| | Rats | 47 | 2025 | 5173 | 1.750 |
Why?
| | Brain | 10 | 2024 | 2628 | 1.440 |
Why?
| | Encephalitis | 6 | 2018 | 132 | 1.400 |
Why?
| | Stress, Physiological | 4 | 2017 | 412 | 1.340 |
Why?
| | Mycobacterium | 5 | 2024 | 111 | 1.220 |
Why?
| | Receptors, Immunologic | 3 | 2019 | 209 | 1.160 |
Why?
| | Alarmins | 4 | 2018 | 24 | 1.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2024 | 108 | 1.010 |
Why?
| | Anti-Inflammatory Agents | 3 | 2023 | 471 | 0.980 |
Why?
| | Animals | 58 | 2025 | 34600 | 0.860 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 9 | 2023 | 153 | 0.860 |
Why?
| | Probiotics | 2 | 2025 | 51 | 0.810 |
Why?
| | Aging | 10 | 2018 | 1771 | 0.790 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 4 | 2012 | 250 | 0.780 |
Why?
| | Interleukin-1beta | 11 | 2023 | 374 | 0.720 |
Why?
| | Cytokines | 12 | 2018 | 1987 | 0.640 |
Why?
| | Limbic System | 1 | 2019 | 46 | 0.630 |
Why?
| | Cisterna Magna | 4 | 2013 | 8 | 0.620 |
Why?
| | Escherichia coli Infections | 4 | 2014 | 106 | 0.580 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 431 | 0.560 |
Why?
| | Mycobacteriaceae | 3 | 2023 | 21 | 0.560 |
Why?
| | Neuroimmunomodulation | 6 | 2019 | 66 | 0.560 |
Why?
| | Memory Disorders | 5 | 2016 | 158 | 0.550 |
Why?
| | Antigens, CD | 2 | 2017 | 483 | 0.530 |
Why?
| | Male | 50 | 2025 | 63194 | 0.510 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 215 | 0.490 |
Why?
| | Central Nervous System | 2 | 2018 | 255 | 0.480 |
Why?
| | Down-Regulation | 1 | 2017 | 634 | 0.480 |
Why?
| | Carrier Proteins | 3 | 2015 | 732 | 0.470 |
Why?
| | Corticosterone | 7 | 2019 | 214 | 0.470 |
Why?
| | Methamphetamine | 1 | 2015 | 56 | 0.470 |
Why?
| | Peripheral Nervous System Diseases | 3 | 2010 | 124 | 0.430 |
Why?
| | Memory | 4 | 2018 | 232 | 0.410 |
Why?
| | Receptors, Interleukin-1 | 2 | 2012 | 223 | 0.400 |
Why?
| | Rats, Inbred F344 | 9 | 2018 | 251 | 0.380 |
Why?
| | Neuroglia | 3 | 2011 | 167 | 0.350 |
Why?
| | Signal Transduction | 3 | 2025 | 4838 | 0.340 |
Why?
| | Mifepristone | 4 | 2019 | 63 | 0.320 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 142 | 0.310 |
Why?
| | Disease Susceptibility | 1 | 2011 | 335 | 0.310 |
Why?
| | Endotoxins | 1 | 2009 | 216 | 0.300 |
Why?
| | RNA, Messenger | 6 | 2020 | 2676 | 0.300 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 940 | 0.300 |
Why?
| | RNA, Antisense | 1 | 2007 | 15 | 0.280 |
Why?
| | Spinal Cord | 7 | 2023 | 354 | 0.270 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2007 | 85 | 0.270 |
Why?
| | Oxidative Stress | 1 | 2013 | 1192 | 0.260 |
Why?
| | Genes, MHC Class II | 1 | 2006 | 72 | 0.260 |
Why?
| | Neuralgia | 2 | 2023 | 120 | 0.250 |
Why?
| | Centrifugation | 1 | 2005 | 29 | 0.250 |
Why?
| | Nerve Tissue Proteins | 1 | 2009 | 568 | 0.250 |
Why?
| | Histocompatibility Antigens | 1 | 2006 | 107 | 0.250 |
Why?
| | Interleukins | 1 | 2006 | 245 | 0.230 |
Why?
| | Diet, Western | 1 | 2024 | 79 | 0.230 |
Why?
| | Cell Separation | 1 | 2005 | 313 | 0.220 |
Why?
| | Immunity, Innate | 4 | 2015 | 805 | 0.220 |
Why?
| | Receptors, Glucocorticoid | 3 | 2016 | 148 | 0.220 |
Why?
| | Dependovirus | 1 | 2024 | 62 | 0.220 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 346 | 0.210 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 7 | 0.190 |
Why?
| | Substance-Related Disorders | 1 | 2011 | 1013 | 0.190 |
Why?
| | Interleukin-6 | 5 | 2023 | 718 | 0.190 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 187 | 0.190 |
Why?
| | Extinction, Psychological | 1 | 2022 | 87 | 0.190 |
Why?
| | Weight Gain | 1 | 2024 | 505 | 0.180 |
Why?
| | Hot Temperature | 2 | 2022 | 364 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 1 | 2024 | 519 | 0.180 |
Why?
| | Phosphate-Binding Proteins | 1 | 2020 | 5 | 0.180 |
Why?
| | Toll-Like Receptor 2 | 2 | 2013 | 110 | 0.180 |
Why?
| | Immunization | 3 | 2018 | 412 | 0.180 |
Why?
| | Proteome | 1 | 2025 | 431 | 0.170 |
Why?
| | Vaccination | 2 | 2020 | 1349 | 0.170 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 816 | 0.170 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 8 | 0.170 |
Why?
| | Interleukin-10 | 4 | 2014 | 299 | 0.170 |
Why?
| | Caspase 1 | 1 | 2020 | 142 | 0.170 |
Why?
| | Hyperalgesia | 3 | 2011 | 109 | 0.160 |
Why?
| | Depressive Disorder | 1 | 2002 | 355 | 0.160 |
Why?
| | Chronic Pain | 1 | 2023 | 254 | 0.160 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 263 | 0.160 |
Why?
| | Killer Cells, Natural | 1 | 2002 | 426 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2021 | 687 | 0.160 |
Why?
| | Interleukin-4 | 1 | 2020 | 213 | 0.160 |
Why?
| | Rats, Inbred BN | 4 | 2012 | 53 | 0.150 |
Why?
| | Circadian Rhythm | 3 | 2018 | 409 | 0.150 |
Why?
| | Receptors, Pattern Recognition | 1 | 2018 | 9 | 0.150 |
Why?
| | Bacterial Vaccines | 1 | 2018 | 62 | 0.150 |
Why?
| | Macrophages | 4 | 2023 | 1466 | 0.150 |
Why?
| | Blood Proteins | 1 | 2020 | 240 | 0.140 |
Why?
| | Cognition | 2 | 2018 | 1111 | 0.140 |
Why?
| | Fear | 4 | 2022 | 325 | 0.140 |
Why?
| | Proteomics | 2 | 2025 | 1010 | 0.140 |
Why?
| | Genetic Therapy | 3 | 2010 | 293 | 0.140 |
Why?
| | Up-Regulation | 2 | 2013 | 828 | 0.140 |
Why?
| | Plasmids | 2 | 2010 | 357 | 0.140 |
Why?
| | Frontal Lobe | 1 | 2018 | 153 | 0.140 |
Why?
| | Time Factors | 6 | 2016 | 6518 | 0.130 |
Why?
| | Lipid Metabolism | 1 | 2020 | 493 | 0.130 |
Why?
| | Neurogenic Inflammation | 1 | 2016 | 2 | 0.130 |
Why?
| | Amygdala | 1 | 2017 | 187 | 0.130 |
Why?
| | Humans | 14 | 2023 | 129116 | 0.130 |
Why?
| | Affect | 1 | 2018 | 285 | 0.130 |
Why?
| | Drug Synergism | 2 | 2013 | 358 | 0.120 |
Why?
| | Adrenalectomy | 2 | 2014 | 67 | 0.120 |
Why?
| | Diet, High-Fat | 1 | 2016 | 238 | 0.120 |
Why?
| | Illness Behavior | 1 | 2014 | 8 | 0.120 |
Why?
| | Anxiety | 2 | 2020 | 955 | 0.120 |
Why?
| | Ventral Tegmental Area | 1 | 2015 | 50 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2013 | 326 | 0.120 |
Why?
| | Circadian Clocks | 1 | 2014 | 42 | 0.110 |
Why?
| | Spleen | 2 | 2014 | 513 | 0.110 |
Why?
| | Prefrontal Cortex | 2 | 2015 | 302 | 0.110 |
Why?
| | Brain Mapping | 1 | 2018 | 571 | 0.110 |
Why?
| | Behavior, Animal | 3 | 2012 | 490 | 0.110 |
Why?
| | Laparotomy | 2 | 2011 | 109 | 0.110 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 128 | 0.110 |
Why?
| | Corpus Striatum | 1 | 2015 | 157 | 0.110 |
Why?
| | Liver | 2 | 2014 | 1833 | 0.110 |
Why?
| | CD11b Antigen | 2 | 2010 | 59 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 347 | 0.110 |
Why?
| | Injections, Spinal | 6 | 2010 | 106 | 0.100 |
Why?
| | Injections | 2 | 2013 | 174 | 0.100 |
Why?
| | Physical Conditioning, Animal | 2 | 2014 | 229 | 0.100 |
Why?
| | Sex Characteristics | 1 | 2018 | 727 | 0.100 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1002 | 0.100 |
Why?
| | Pain | 4 | 2011 | 760 | 0.090 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2011 | 38 | 0.090 |
Why?
| | DNA | 2 | 2010 | 1392 | 0.090 |
Why?
| | Interleukin-1 | 2 | 2007 | 961 | 0.090 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 43 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 1945 | 0.090 |
Why?
| | Raphe Nuclei | 1 | 2011 | 111 | 0.090 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2010 | 57 | 0.090 |
Why?
| | Immune System | 1 | 2012 | 177 | 0.090 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2012 | 177 | 0.090 |
Why?
| | Transcription Factors | 1 | 2018 | 1632 | 0.080 |
Why?
| | Fever | 1 | 2011 | 301 | 0.080 |
Why?
| | Genes, fos | 1 | 2009 | 33 | 0.080 |
Why?
| | Microfilament Proteins | 1 | 2010 | 125 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2010 | 2508 | 0.080 |
Why?
| | Hyperesthesia | 2 | 2006 | 7 | 0.080 |
Why?
| | Calcium-Binding Proteins | 1 | 2010 | 211 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2010 | 162 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 360 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2012 | 497 | 0.070 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2009 | 134 | 0.070 |
Why?
| | Hydrocortisone | 1 | 2009 | 304 | 0.070 |
Why?
| | Neuronal Plasticity | 1 | 2009 | 264 | 0.070 |
Why?
| | Foreign-Body Reaction | 1 | 2007 | 26 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1192 | 0.070 |
Why?
| | Pain Threshold | 1 | 2007 | 72 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2018 | 4010 | 0.060 |
Why?
| | Catheterization | 1 | 2007 | 170 | 0.060 |
Why?
| | Immunohistochemistry | 2 | 2010 | 1671 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2006 | 267 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2013 | 3953 | 0.060 |
Why?
| | Minocycline | 1 | 2005 | 27 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 510 | 0.060 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 11 | 0.060 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 88 | 0.060 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 10 | 0.060 |
Why?
| | Constriction | 1 | 2023 | 42 | 0.050 |
Why?
| | Transduction, Genetic | 1 | 2024 | 128 | 0.050 |
Why?
| | Morphine | 1 | 2004 | 129 | 0.050 |
Why?
| | Leptin | 1 | 2024 | 218 | 0.050 |
Why?
| | Transgenes | 1 | 2024 | 177 | 0.050 |
Why?
| | Animals, Genetically Modified | 1 | 2024 | 232 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 759 | 0.050 |
Why?
| | Genetic Vectors | 1 | 2024 | 311 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 221 | 0.050 |
Why?
| | Electroshock | 2 | 2013 | 143 | 0.050 |
Why?
| | Tissue Distribution | 2 | 2016 | 291 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2006 | 818 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2012 | 2496 | 0.040 |
Why?
| | Age of Onset | 1 | 2002 | 494 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2002 | 523 | 0.040 |
Why?
| | Adiposity | 1 | 2024 | 505 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1689 | 0.040 |
Why?
| | Escherichia coli | 2 | 2016 | 771 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2002 | 1142 | 0.040 |
Why?
| | Pain Measurement | 2 | 2011 | 487 | 0.040 |
Why?
| | Optical Fibers | 1 | 2018 | 18 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2018 | 69 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2004 | 1109 | 0.040 |
Why?
| | Immunoassay | 1 | 2018 | 103 | 0.040 |
Why?
| | Neurons | 1 | 2006 | 1456 | 0.040 |
Why?
| | Mice | 2 | 2024 | 16644 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 636 | 0.030 |
Why?
| | Host-Pathogen Interactions | 2 | 2011 | 348 | 0.030 |
Why?
| | Memory, Long-Term | 1 | 2016 | 12 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 624 | 0.030 |
Why?
| | Hormone Antagonists | 1 | 2016 | 30 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2004 | 908 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2023 | 1423 | 0.030 |
Why?
| | Antibodies | 1 | 2018 | 391 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 346 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2016 | 398 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 9 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5284 | 0.030 |
Why?
| | Phenotype | 1 | 2002 | 3058 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2020 | 518 | 0.030 |
Why?
| | Proteins | 1 | 2020 | 936 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 305 | 0.030 |
Why?
| | Conditioning, Classical | 1 | 2014 | 99 | 0.030 |
Why?
| | Injections, Intraventricular | 1 | 2012 | 53 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2737 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 146 | 0.020 |
Why?
| | Obesity | 1 | 2024 | 2863 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2011 | 90 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2011 | 76 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3184 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2010 | 93 | 0.020 |
Why?
| | Polyglycolic Acid | 1 | 2010 | 42 | 0.020 |
Why?
| | Female | 3 | 2023 | 68510 | 0.020 |
Why?
| | Serotonin | 1 | 2011 | 318 | 0.020 |
Why?
| | Amnesia, Anterograde | 1 | 2008 | 3 | 0.020 |
Why?
| | Particle Size | 1 | 2010 | 352 | 0.020 |
Why?
| | Exercise Test | 1 | 2011 | 615 | 0.020 |
Why?
| | Action Potentials | 1 | 2011 | 471 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 295 | 0.020 |
Why?
| | Parietal Lobe | 1 | 2008 | 48 | 0.020 |
Why?
| | Hypothalamus | 1 | 2008 | 144 | 0.020 |
Why?
| | Cyclooxygenase 1 | 1 | 2007 | 26 | 0.020 |
Why?
| | Microinjections | 1 | 2006 | 76 | 0.020 |
Why?
| | Ligation | 1 | 2006 | 87 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 718 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2006 | 60 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 172 | 0.020 |
Why?
| | Nanoparticles | 1 | 2010 | 368 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2007 | 465 | 0.010 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 20 | 0.010 |
Why?
| | Receptors, HIV | 1 | 2004 | 26 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 23 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2010 | 886 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 35 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 758 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 83 | 0.010 |
Why?
| | Neuroprotective Agents | 1 | 2005 | 109 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 152 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1271 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 320 | 0.010 |
Why?
| | Middle Aged | 1 | 2002 | 31074 | 0.010 |
Why?
| | Adult | 1 | 2002 | 35510 | 0.010 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|